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summary
Lung-stage schistosomula are the target of protective immunity in mice vaccinated with attenuated cercariae of Schistosoma
mansoni. Therefore, proteins present at this developmental stage, and in particular those which are secreted, are a potential
source of novel vaccine candidates. However, little information is available about such molecules. Here we describe the
cDNA clones identified by screening expression libraries with serum raised against proteins released by lung-stage
schistosomula. In total, 11 different cDNA species were identified, 6 of which have been described previously in S.
mansoni ; these included fructose 1,6-bisphosphate aldolase and Sm21\7 which together accounted for two-thirds of all
positive clones. Of the 5 newly described schistosome genes, 1 cDNA had a high degree of homology to the s5a subunit
of 26S proteasomes, most signifcant being with the human protein. The remaining 4 clones showed no significant
homologies to any genes sequenced previously. Fructose 1,6-bisphosphate aldolase, Sm21\7, the proteasome homologue
and 1 unknown clone (A26) have been expressed in a bacterial expression system and serum produced against each
recombinant protein. Immunolocalization showed fructose 1,6-bisphosphate aldolase, Sm21\7 and the proteasome hom-
ologue to be most abundant in muscle cells whilst clone A26 was distributed throughout many tissues, but was most
abundant in the tegument. Analysis of the cellular immune responses of vaccinated mice showed 3 of the 4 expressed
clones to be highly immunogenic, inducing the secretion of large quantities of the Th1-type cytokine interferon gamma.
Key words: Schistosoma mansoni, released proteins, sequence analysis, immunolocalization, immune response.
introduction
It is well established that the immunization of mice
with radiation-attenuated cercariae of Schistosoma
mansoni induces consistently high levels of resistance
against a subsequent challenge with normal parasites
(reviewed by Coulson, 1997). Dissection of the
murine immune response in this model has
facilitated the identification of several parameters
which are essential for the development of pro-
tection. For example, it is clear that T cells play a
pivotal role in the expression of resistance in mice
singly-vaccinated with attenuated cercariae (Vignali
et al. 1989). More specifically, ablation of the Th1-
associated cytokine interferon gamma (IFNc), at the
time of challenge, results in almost total abrogation
of immunity (Smythies, Coulson & Wilson, 1992a).
Despite the information which has accumulated
detailing the immunological aspects of both the
induction of immunity and the effector mechanism,
little is known about the antigen(s) which elicit these
responses. However, from the information available
regarding the nature of the induction and effector
mechanisms, several deductions can be made about
the source of such molecules. Since attenuated
parasites fail to develop beyond the lung-stage,
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proteins unique to the adult worm can be discounted
as important inducers of immunity in this model
system. In addition, it has been shown that
attenuated lung-stage schistosomula administered
intradermally are capable of eliciting high levels of
protection against a subsequent challenge infection
(Coulson & Mountford, 1989). Thus, antigens
specific to the cercaria are not required for the
induction of immunity. As parasite elimination
occurs in the lungs and is T cell-mediated we can
further conclude that it must be triggered by
antigen(s) released from the live challenge schisto-
somulum for processing by accessory cells and
subsequent presentation to pulmonary Th cells.
The pattern of proteins released by lung-stage
schistosomula during in vitro culture has been
described previously (Harrop & Wilson, 1993). Such
molecules were found to be the most potent
stimulators of IFNc secretion by T cells recovered
from the lymph nodes and lungs of vaccinated mice,
compared to proteins derived from other life-cycle
stages (Mountford, Harrop & Wilson, 1995). Since
the protective immune mechanism depends upon a
strong pulmonary Th1 response (Coulson, 1997) the
proteins released by lung schistosomula are a
potential source of vaccine candidates and, as such,
worthy of more detailed analysis.
Only minute quantities of protein are released by
larval parasites, making a detailed study of their
function, immunogenicity and vaccine potential
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difficult. For this reason, serum was raised against
such antigens and used to screen cercarial, lung-
stage schistosomula and adult worm cDNA libraries.
Positive clones have been purified, the nucleotide
sequence determined and used to search DNA and
amino acid databases to identify homologies. Several
clones, selected for further study, were expressed in
a bacterial high-level expression vector and the
resulting purified protein used to produce antiserum.
Each serum was used to immunolocalize the native
protein in sections of cercariae, lung-stage schisto-
somula and adult worms and to probe Western blots
of different parasite preparations. Such studies
provide an insight into the tissue distribution and
function of each molecule. In addition, the immuno-
genicity of each recombinant protein was assessed by
measuring proliferation and cytokine production by
cells recovered from vaccinated mice.
materials and methods
Preparation of parasite antigens
The life-cycle of S. mansoni was maintained in the
laboratory by routine passage through the inter-
mediate snail host Biomphalaria glabrata and MF1
mice. Soluble protein preparations of cercariae
(SCAP), lung-stage schistosomula (SLAP) and adult
worms (SWAP) and proteins released by schisto-
somula cultured in vitro during the first 3 h and
between day 6 and day 8 post-transformation were
produced as described previously (Harrop & Wilson,
1993). Skin-stage (0–3 h RPs) and lung-stage
(6–8 day RPs) parasite-released material was concen-
trated by centrifugation in Ultrafree centrifugal filter
devices (Millipore) containing 5 kDa cut-off mem-
branes, and the protein concentration estimated
subsequently by the Bradford assay. In addition,
lung worms ranging from 6 to 8 days old were frozen
at fi70 °C until required as a source of mRNA.
Generation of a lung-stage schistosomula cDNA
library
It is not known whether the protective antigens
which mediate lung-phase immunity are stage
specific or are expressed throughout the parasite life-
cycle. In order to maximize the chances that the
relevant molecular species were present, mRNA was
extracted using the MicroFast track kit (Invitrogen)
from approximately 3‹10’ schistosomula which had
been cultured in vitro for 6, 7 or 8 days (i.e. to the
lung stage of development). The mRNA was
subsequently packaged into the kZAP II vector by
Stratagene. Two additional libraries were used
throughout the course of these studies, a cercarial
and an adult worm cDNA library which were kindly
donated by Dr E. Dias Neto and Dr R. Pierce.
Production of antisera to schistosomula-released
proteins and recombinant proteins
Antisera against 6–8 day RPs were produced by
immunizing rabbits subcutaneously with approxi-
mately 20 lg of the heterogeneous antigen prep-
aration emulsified in Complete Freund’s adjuvant
for the primary inoculation and in Incomplete
Freund’s adjuvant for the 2 subsequent boosts. The
antibody titre against 6–8 day RPs was assessed by
ELISA (data not shown) and deemed to be sufficient
after 2 boosts. Antisera against purified recombinant
proteins were produced in the same manner with the
exception that mice with a disrupted IFNc receptor
gene (129 IFNcR−/−) were used. Approximately
10 lg of purified recombinant protein were
administered per mouse in both primary inoculations
and in subsequent boosts.
Western blotting
Proteins were separated electrophoretically through
12% polyacrylamide gels under reducing conditions
according to the method of Laemmli (1970). Either
5 lg (heterogeneous antigen preparations) or 0–5 lg
(recombinant) protein was loaded per lane. Resolved
fractions were electroblotted onto Immobilon-P
membrane (Millipore, Watford, UK) and probing of
the blots was carried out subsequently as described
by Cutts & Wilson (1997).
Screening of cDNA libraries
The cDNA libraries were screened essentially as
described by Huynh, Young & Davis (1986).
Nitrocellulose filters (Sartorius), were probed with
primary antiserum diluted to 1:200 and positive
clones visualized following staining with DAB.
Recombinant bacteriophage were isolated from the
test plate and purified to homogeneity by several
rounds of re-screening.
Plasmid DNA preparation and sequence analysis
cDNA inserts from positive clones were subcloned
into pBluescript using the Helper phage R408
(Stratagene) according to the manufacturer’s
instructions. Subsequently, plasmid DNA was
isolated using a plasmid purification kit (Qiagen) and
the purity and yield quantified spectrophometrically.
Purified plasmids were sequenced using a Dye
Deoxy terminator cycle sequencing kit (ABI) ac-
cording to the manufacturer’s recommendations.
Products were electrophoresed and analysed on an
Applied Biosystems Model 373A DNA sequencing
system. The resulting cDNA sequence was edited
and any homology to previously sequenced genes
determined by searching the GenBank and
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Fig. 1. Western blot of SCAP, 0–3 h RPs, SLAP,
6–8 day RPs and SWAP probed with antiserum raised
against 6–8 day RPs (diluted to 1:100). 5 lg of each
protein was electrophoresed on 12% acrylamide gels.
Molecular weights are illustrated.
SwissProt databases using software developed by
the Genetics Computer Group, University of
Wisconsin, Madison, WI. A number of cDNA clones
were sequenced in their entirety. In such cases,
primer walking from both 5« and 3« ends was
undertaken and the resulting sequences assembled
into contigs using the Fragment Assembly System
(GCG).
High-level expression
A number of clones were selected for expression in a
prokaryotic high-level expression system (pQe;
Qiagen). Suitable restriction sites were chosen and
cDNA inserts digested out of the recombinant
pBluescript and subsequently ligated into the ap-
propriate expression vector thus maintaining the
open reading frame. Recombinant protein expression
was undertaken according to the manufacturer’s
protocol. Subsequently, cells were harvested by
centrifugation and the histidine-tagged proteins
purified under denaturing conditions by Ni-NTA
resin chromatography. Where required, purified
proteins were dialysed extensively against decreasing
concentrations of urea and finally against phosphate-
buffered saline, pH 7–2.
Immunocytochemistry
Cercariae, lung-stage schistosomula and adult
worms were prepared for immunocytochemistry
based on the methodology developed by
Riengrojpitak et al. (1989). Briefly, cercariae or
cultured lung worms were pelleted in Eppendorf
tubes by low-speed centrifugation. Ten freshly
perfused and washed adult worms were hand-
counted and pipetted into Eppendorf tubes in a
small volume of RPMI-1640 medium (Gibco).
Subsequently, parasites were mixed in optimum
cutting temperature compound (OCT; Tissue-Tek,
London, UK) on a cork disc and plunged into
isopentane which had been pre-cooled in liquid
nitrogen. Discs were then stored at fi70 °C. All
subsequent steps were performed as detailed pre-
viously (Riengrojpitak et al. 1989). Stained sections
were examined under a Nikon fluorescence micro-
scope and photographed on Kodak Ektachrome,
ASA 400.
Assays of lymphocyte proliferation and cytokine
production
Assays were undertaken as detailed previously
(Mountford et al. 1995). Briefly, axillary lymph
nodes were removed from 3 female C57Bl}6 mice 5
days after vaccination with 500 irradiated cercariae.
Irradiated splenocytes were used as a source of
antigen-presenting cells, at a concentration of
2‹10&}well. Lymph node cells were used at 10&}
well and stimulated with different antigens at a
concentration of 0–5 lg}well. Soluble parasite
preparations were used as positive controls and 2
pure non-schistosome proteins (BSA and b-
galactosidase) served as negative controls. b-gal was
expressed and purified in the pQe high level
expression vector and therefore represents a good
control for recombinant protein purity. Cells were
also recovered by bronchoalveolar lavage from the
lungs of mice 21 days after percutaneous exposure to
irradiated cercariae as detailed by Smythies et al.
(1992b).
Culture supernatants were removed at 72 h and
stored at fi80 °C for subsequent analysis of cytokine
production which was undertaken using specific
double-antibody ELISA as detailed previously
(Mountford et al. 1995). Secretion of the type 1
and type 2 indicator cytokines, IFNc and IL-4
respectively, was measured. No other cytokines
were analysed in this study. Results illustrated are
representative of 2 (lung) or 3 (lymph node)
individual experiments. Where appropriate, the
mean‡standard deviation has been plotted.
results
Western blotting
The antiserum raised against lung-stage released
proteins was used to probe Western blots of SCAP,
0–3 h RPs, SLAP, 6–8 day RPs, and SWAP (Fig. 1).
Between 5 and 20 proteins, ranging in molecular
weight from 10 to 100 kDa were visible in the
different antigen preparations. By far the most
dominant band was one of approximately 50 kDa
which was highly represented in SCAP and
0–3 h RPs, but barely visible in 6–8 day RPs. Most
of the molecules detected in the lung-stage released
proteins could also be found in the more complex
soluble parasite preparations. However, there are
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Table 1. Summary of the predicted identity of cDNA clones following homology searches of the
GenBank and SwissProt databases
(The table details clones identified from cercarial, lung-stage schistosomula and adult worm cDNA libraries by screening
with antiserum raised against lung worm released proteins.)
Clone identity
cDNA
library Number Percentage
S. mansoni Fructose 1,6-bisphosphate aldolase Cercarial 10 17–2
S. mansoni 21–7 kDa antigen Cercarial 9 15–5
S. mansoni Calcium-binding protein Cercarial 1 1–7
Unknowns Cercarial 2 3–4
S. mansoni Fructose 1,6-bisphosphate aldolase Lung 10 17–2
S. mansoni 21–7 kDa antigen Lung 9 15–5
S. mansoni Paramyosin Lung 3 5–2
S. mansoni Myosin Lung 1 1–7
Unknowns Lung 2 3–4
S. mansoni Paramyosin Adult 4 6–9
S. mansoni Myosin Adult 4 6–9
S. mansoni Calpain Adult 2 3–4
Unknowns Adult 1 1–7
obvious differences in the profile of proteins detected
at the lung and adult worm stages, compared to those
in SCAP and 0–3 h RPs, suggesting some stage-
specific expression.
cDNA library screens
Having established that the anti-6–8 day RP serum
was capable of detecting several antigens in a denat-
ured form, cDNA library screening was undertaken.
Approximately 3‹10’ pfu were sampled in the 3
different libraries ; 22 positive clones were detected
in the cercarial, 25 in the lung-stage and 11 in the
adult worm library. After purification to homogen-
eity, all positive clones were sequenced, initially
from the 5« end. A summary of the clone identities
following single-pass sequencing is given in Table 1.
Of the 11 different cDNAs identified, 6 had
homology with previously sequenced S. mansoni
genes, and 5 had no database matches. The most
commonly identified molecules by library screening
were the glycolytic enzyme fructose 1,6-bisphosphate
aldolase, which alone accounted for more than one-
third of all positive clones, and the 21–7 kDa antigen.
Full-length sequence analysis
Following single-pass sequence analysis, clones
CL1, CL22, NLSL19, NLSL24 and A26 were
found to have no homology to anything deposited in
GenBank or SwissProt. Therefore, full-length se-
quence analysis was undertaken by primer walking
from both 5« and 3« ends.
(a) Clones CL1, CL22 and NLSL24 (Accession
numbers: AF030963, AF030964 and AF030962
respectively). Clone CL1, identified from the
cercarial cDNA library, contains an insert of
0–43 kBa and a single open reading frame of 92 amino
acids which encodes a protein of predicted molecular
weight 10–6 kDa. CL22, also identified from the
cercarial library, contains an insert of 0–41 kBa and a
small open reading frame of 52 amino acids which
would code for a protein fragment of predicted
molecular weight 6–5 kDa. Clone NLSL24,
identified from the lung-stage library contains an
insert of 0–42 kBa and encodes a protein of 119 amino
acids which ends with an in-frame stop codon
(UAA) at position 359. The predicted molecular
weight of the protein is 13 kDa. Even when the
complete cDNA sequence was known, searches of
both GenBank and SwissProt databases showed no
significant matches for any of these 3 clones.
(b) NLSL19 (Accession number: AF030960). Clone
NLSL19, identified from the lung-stage larval
cDNA library, contained an insert of 1–45 kBa which
was sequenced from both 5« and 3« ends. The clone
was found to contain a single open reading frame of
427 amino acids which ends with an in-frame UAA
stop codon at bp position 1282. The predicted
molecular weight of the protein is 46–5 kDa with a pI
of 4–65. The deduced amino acid sequence was found
to have 51% identity over a 327 aa overlap with a
human 26S proteasome subunit 5a (U51007) as well
as significant yet lower homology with the Drosophila
melanogaster, Arabidopsis thaliana and yeast 26S
proteasome homologues. Figure 2 shows a multiple
sequence alignment of clone NLSL19 with both
human and D. melanogaster 26S proteasomes. It can
be seen that the first 250 N-terminal amino acids and
the extreme C-terminus are highly conserved be-
tween all 3 proteins. With the exception of an
additional 19 amino acids starting at position 293 in
the human proteasome and 33 amino acids in the S.
mansoni homologue at position 360, few gaps are
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Fig. 2. Multiple sequence alignment of Drosophila melanogaster and human S5a 26S proteasome sequences and clone
NLSL19. Identities are illustrated in the consensus line and gaps (\) introduced to optimize the alignment.
required for optimal alignment of the 3 sequences.
The schistosome cDNA clone does not appear to
have a start codon which adheres to the
ANN.ATG.G motif commonly found in eukaryotes.
However, from the alignment, it can be seen that the
first methionine at position 22 lines up with the start
codons of the human and Drosophila molecules. It is
possible therefore that this may represent the start
codon of the schistosome cDNA.
(c) Clone A26 (Accession number: AF030965).
Clone A26 contains an 800 bp insert with a single
open reading frame of 171 amino acids which ends
with an in-frame stop codon (UAA) at base pair
position 514. From the deduced amino acid se-
quence, a protein of 19 kDa with a pI of 8–59 would
be predicted. Homology searches at SwissProt
showed small, yet significant similarities between the
schistosome protein and a D. melanogaster lethal (1)
discs large-1 tumour suppressor protein (P31007;
40% identity in 120 amino acid overlap) and a rat
presynaptic density protein (P31016; 31% in 145
amino acid overlap). The homologies occur within
an area known as disc homologous region 3 of both
molecules. The deduced amino acid sequence
contains a putative N-glycosylation site at amino
acid residues 38–41 and an RGD motif exists at
110–112.
High-level expression
In total, 4 clones have been expressed and purified in
the pQe high level expression vector; these include
the previously cloned S. mansoni fructose 1,6-
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Fig. 3. Western blots of the target recombinant protein alongside SCAP, SLAP and SWAP probed with sera (1:100)
against CL20 (A), NLSL2 (B), NLSL19 (C) and A26 (D). Samples of 5 lg soluble protein preparations and 0–5 lg
recombinant protein were loaded per lane. Molecular weights are illustrated.
bisphosphate aldolase (CL20) and 21–7 kDa antigen
(NLSL2) and the newly identified clones NLSL19
and A26. We were not able to express CL1, CL22 or
NLSL24 in the pQe expression vector. The
estimated molecular weights of each expressed
recombinant protein were as follows: CL20, 35 kDa;
NLSL2, 25 kDa; NLSL19, 56 kDa and A26, 19 kDa
(data not shown). With the exception of clone
NLSL19, the observed and expected molecular
weights were very similar. The predicted molecular
weight of NLSL19, however, is 46–5 kDa, a disparity
of almost 10 kDa. The reason for this is not entirely
clear.
Abundance and identification of ‘native ’ protein in
different life-cycle stages
The full-length target protein of each serum was
identified by probing Western blots of SCAP, SLAP
and SWAP (6–8 day RPs were not used for blotting
because of the difficulty obtaining sufficient
quantities). Figure 3 shows a panel of Western blots
probed with serum against clones CL20, NLSL2,
NLSL19 and A26. Antiserum against clone CL20
bound to the recombinant protein at 35 kDa, but in
all 3 soluble preparations detected proteins at
approximately 39 kDa (the predicted molecular
weight of fructose 1,6-bisphosphate aldolase). In
SCAP and SWAP, the antiserum recognized a
doublet or possibly even a triplet of proteins of very
similar molecular weight. Antisera against clones
NLSL2 and NLSL19 bound strongly to their target
recombinant proteins but only weakly to the full
length molecule in any of the soluble preparations.
Antiserum raised against clone A26 detected the
19 kDa target recombinant protein strongly and a
protein of 30 kDa in all soluble parasite preparations.
Immunolocalization
Each serum was used to probe cryostat-cut sections
of cercariae, lung-stage schistosomula or adult
worms. Immunolocalization of each target protein is
illustrated in Fig. 4. Clones CL20 (aldolase; Fig.
4A, B), NLSL2 (Sm21\7; Fig. 4E) and NLSL19
(proteasome homologue; Fig. 4C, D) all appeared
to be most abundant in the muscle cells of the
parasite. The anti-aldolase serum also bound to
discrete foci of proteins within the cercaria, which
could potentially be flame cells ; in the adult worm
the tegument was weakly positive. Antiserum against
clone A26 (Fig. 4F) bound throughout all tissues but
was strongest in the tegument.
Lymphocyte proliferation and cytokine production
The level of [$H]thymidine incorporation by axillary
lymph node cells, recovered from mice 5 days after
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Fig. 4. Immunolocalization of clones CL20 (fructose 1,6-bisphosphate aldolase; (A, B), NLSL19 (C, D), NLSL2
(Sm21\7; E) and A26 (F) in sections of cercariae (A, E), lung-stage schistosomula (C, F) and adult worms (B, D).
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Fig. 5. Proliferative responses (A) and IFNc production (B) and (C) by axillary lymph node cells recovered from
mice 5 days after vaccination with irradiated cercariae (A and B) and from the lungs of mice 21 days post-vaccination
(C) following stimulation with 0–5 lg antigen. Proliferative responses are expressed as counts per minute‡s.d. from
triplicate wells. Representative results from 3 separate experiments are illustrated. IFNc production is expressed as
pg}ml following extrapolation from a standard curve.
vaccination, in response to different proteins is
illustrated in Fig. 5A. Three of the 4 recombinants
(NLSL2, NLSL19 and CL20) induced significantly
higher levels of proliferation than the negative
controls. The aldolase (CL20) caused greater cellular
proliferation than the heterogeneous soluble prep-
aration (SLAP) used as a positive control.
When cytokine production by lymph node cells
was analysed, IL-4 was not detectable (data not
shown). However, all recombinants induced greater
levels of IFNc secretion than the negative controls
(Fig. 5B). In particular, when compared to SLAP,
the aldolase induced more than 7 times the amount
of IFNc secretion. When cytokine production by
cells recovered from the lungs of vaccinated mice
was analysed, an even stronger response to A26 and
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CL20 was observed with IFNc production ap-
proaching 6000 pg}ml (Fig. 5C).
discussion
By probing Western blots with antiserum raised
against lung-stage released proteins, we have
identified molecules present in lung and other stages
of the parasite life-cycle. Quantitatively, more
molecules were detected in the 6–8 day RPs, against
which the antiserum was raised, than in other
fractions. However, the most dominant band
recognized by this antiserum (50 kDa), was highly
represented in both SCAP and 0–3 h RPs yet poorly
represented in 6–8 day RPs and absent in other
preparations, suggesting that it is highly immuno-
genic and expressed preferentially in earlier life-
cycle stages. By screening cDNA libraries with
antiserum raised against lung-stage released
proteins, we have identified clones which encode
both novel and previously characterized schistosome
molecules. We believe this to be the first report of a
strategy which specifically aimed to identify cDNA
clones encoding antigens derived from lung worms.
In total, 11 cDNAs encoding different proteins were
isolated by library screening. Whether these rep-
resent molecules which are either excreted, secreted
or released from the nephridia, gut or tegument is
difficult to say. The two most frequently identified
clones were found to encode the 39 kDa glycolytic
enzyme fructose 1,6-bisphosphate aldolase and the
Sm21\7 antigen. Together, these proteins accounted
for 66% of all positive clones, but were only
identified in the cercarial and lung-stage parasite
cDNA libraries.
It is difficult to determine whether the aldolase
and Sm21\7 are quantitatively the most common
proteins found in the material released by lung
worms, are relatively scarce but highly immunogenic
and therefore yield serum with high aldolase and
Sm21\7 antibody titres or, are simply very abundant
in the 2 cDNA libraries. The fact that no dominant
bands are seen at 39 kDa or 21–7 kDa following
Western blotting with the 6–8 day RP antiserum
supports the last hypothesis. In this respect, by using
the lung-stage cDNA library as a source of expressed
sequence tags, Franco et al. (1997) found that the
aldolase accounted for 1–5% of all clones sampled
whereas Sm21\7 was not identified. It is unclear why
a glycolytic enzyme should be released by lung-stage
schistosomula. However, other proteins involved in
glycolysis such as PGK, TPI and G3PDH have been
found on the surface of newly-transformed schisto-
somula (Lee et al. 1995; Harn et al. 1985; Goudot-
Crozel et al. 1989, respectively) and therefore liable
to release upon turnover of the tegument. The role of
such molecules in this somewhat unusual location is
not clear, although it has been postulated that they
provide energy for repair of the tegument (Lee et al.
1995). Both the aldolase and Sm21\7 have been
characterized previously (Doenhoff, 1998; Francis &
Bickle, 1992, respectively), and their potential as
vaccine candidates demonstrated. Stage-specific
antigenic differences were noted for the aldolase, for
which various explanations have been postulated;
these included differential glycosylation, post-trans-
lational stage-dependent conformational changes
and differential mRNA splicing. Such differences
may account for the blotting pattern observed with
the aCL20 serum.
Myosin and paramyosin were identified in both
lung-stage and adult worm cDNA libraries. Since
such molecules are associated with muscle, it would
seem unlikely that they are released during mem-
brane turnover by lung-stage larvae. However, there
have been suggestions that paramyosin could be a
secreted protein (Laclette et al. 1991; Nara et al.
1994). In addition, S. mansoni myosin and
paramyosin are both vaccine candidates ; therefore
the immune system must be exposed to both
molecules during the course of a challenge infection
to enable subsequent immune-mediated parasite
killing.
Clone NLSL19 was found to have significant
sequence homology to the S5a subunit of the 26S
proteasome of different species. The 26S proteasome
is composed of 2 subcomplexes, the 20S proteasome
(or multicatalytic protease) which contains the
catalytic core of the protease, and the 19S regulatory
complex. The 26S proteasome degrades ubiquitin-
tagged proteins into small peptides and plays an
important role in the selective degradation of
abnormal}dysfunctional polypeptides. Subunit 5a of
the proteasome, is thought to be the essential
ubiquitin recognition component of the complex.
cDNA clones encoding subunit 5a have been
described previously in humans (Ferrel et al. 1996),
D. melanogaster and A. thaliana (Van Nocker et al.
1996) and found to encode proteins of 40–3, 54 and
41 kDa respectively. The similar molecular weight,
pI and significant sequence homology of NLSL19 to
other known 26S proteasomes lead us to conclude
that this clone encodes the schistosome homologue
of such proteins. As far as we are aware, there has
been no suggestion that such proteins are secreted
and no signal peptide has been identified. In
addition, immunolocalization of NLSL19 showed
the protein to be associated primarily with muscle
cells, therefore the process by which this protein is
released is unclear.
Clone A26 shared some homology to 2 previously
sequenced genes, although this did not provide
insights into the molecule’s function. The difference
in molecular weight between the recombinant
protein (19 kDa) and the molecule detected by
the serum (30 kDa) suggests that the cDNA is
incomplete. From the nucleotide sequence, it would
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appear that the 5« end is missing, therefore the
identification of a putative leader sequence is
impossible. Immunolocalization of A26 showed
staining which was diffuse throughout many tissues,
but strongest in the tegument. Although this does
not provide compelling evidence that the protein
is secreted or of membrane origin, the presence of
N-glycosylation and cell attachment motifs (RGD)
may be circumstantial evidence for a surface}
secretory origin. RGD motifs are known to mediate
many cell–cell and microbe–host interactions. In par-
ticular, the cellular matrix proteins vitronectin and
fibronectin use this tripeptide to bind integrins pre-
sent on cell surfaces. A number of viruses have been
shown to use the RGD tripeptide to interact with cell
receptors thus facilitating infection (Pulli, Koivunen
& Hyypia, 1997). In addition, Plasmodium falciparum
has also been found to contain the RGD sequence in
the TRAP protein (Robson et al. 1988). This protein
is expressed during the erythrocytic stage of the
parasite life-cycle and may facilitate cellular
invasion. Since schistosomes are extracellular
parasites, we can only speculate what role, if any,
this cell attachment motif is playing. It is possible
that it could function as an intercellular cement.
Alternatively, if exposed on the surface, the protein
might provide a means by which host cells could
adhere to the parasite thereby masking its presence
from specific effector cells of the immune system.
Clones CL1, CL22 and NLSL24 showed no
significant homology to any sequence deposited in
GenBank to date and therefore likely represent novel
genes. Since we were unable to express these clones
in the pQe vector and thus raise antisera, it is
impossible to speculate on the encoded protein’s
origin or function. One means of ascertaining
whether a protein is secreted or transmembrane, is
the presence of a signal peptide. The deduced amino
acid sequence of each clone was submitted to an
algorithm which predicts putative signal peptides
(PSORT Prediction: http:}}psort.nibb.ac.jp).
Clone CL1 appeared to have a cleavable signal
peptide beginning at the second methionine. Analy-
sis of the primary nucleotide sequence showed the
flanking residues of the second ATG triplet to
adhere to the ANN.ATG.G motif suggesting that
this could be the start codon of the molecule. The
presence of a signal peptide is known to be
problematic in some high level expression systems
and therefore may provide one explanation why we
were unable to express this clone. The 5« ends of
clones NLSL24 and CL22 are lacking, indeed the
deduced amino acid sequences contain no meth-
ionine residues, thus making it impossible to identify
putative signal sequences Different high level ex-
pression vectors must be tested to try to find one
suitable for the production of recombinant proteins
from clones CL1, CL22 and NLSL24 and thus
enable more detailed characterization.
The immunogenicity of the 4 expressed recom-
binant proteins was assessed by measuring cellular
proliferation and production of the cytokines, IFNc
(type 1) and IL-4 (type 2). In this respect, we have
demonstrated previously that the proteins secreted
by lung-stage schistosomula are the most potent
stimulators of IFNc production by cells recovered
from both lymph nodes and lungs of vaccinated
mice. By cloning and expressing individual
constituents of this heterogeneous subset of parasite
proteins, we have been able to dissect the con-
tribution that each makes to the immune response
observed. Two of the 4 expressed recombinants
elicit potent Th1-type immune responses by cells
recovered from both lymph nodes and lungs of
vaccinated mice. The quantity of IFNc released in
response to A26 and in particular to CL20 (aldolase)
is very high and in both cases is greater than that
caused by the soluble antigen preparation (SLAP)
used as a positive control. Considering the number
of antigens present in SLAP and therefore the
number of T cell epitopes, this is perhaps surprising.
Several explanations may exist. Since SLAP
represents a complex mixture of proteins, it may
contain molecules which promote or possibly down-
regulate IFNc production. Alternatively, it has been
demonstrated previously that by day 21 post-
vaccination, cells recovered by BAL from the lumen
of mice are highly enriched with parasite-specific
Th1 cells (Mountford et al. 1992; Coulson & Wilson,
1993). However, the extent of this schistosome-
specific T cell repertoire is not known. It is possible
that a large number of these cells are specific for a
small number of epitopes. If such epitopes are
contained in the recombinant proteins detailed here,
a strong response might be predicted. Since immune
elimination of challenge parasites in the irradiated
cercaria vaccine model is dependent upon the
secretion of IFNc in the lungs, these results are
promising in the search for new vaccine candidates.
We have employed a strategy which set out to
identify proteins excreted, secreted or released by
lung-stage schistosomula. Various criteria were ap-
plied to ascertain whether this goal had been
achieved; these included sequence analysis of the
identified clones, homology searches and immuno-
localization of the encoded protein. It would appear
that not all of the identified clones fulfill our initial
criteria. Some encode proteins which are likely to be
associated exclusively with muscle (myosin and
paramyosin) or be cytosolic (calpain). One possible
explanation for this finding is that some of the clones
represent material leaked into the culture medium by
the 1–5% of dead}dying parasites present in most
cultures. Such proteins are likely to be abundant and
immunogenic. Conversely, since schistosomes have
evolved to survive in the potentially hostile en-
vironment of the host’s bloodstream, those molecules
secreted by schistosomula, unless being used as an
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immunological smoke screen, are likely to be rare
and poorly immunogenic (at least in the permissive
human host). This would make them more difficult
to characterize. However, in mice, immune
responses to the 4 expressed recombinants were
strong. In order to generate such a response, the
immune system must be exposed to the target
proteins. Since few if any attenuated parasites have
died by day 5 (the time of lymph node removal) post-
vaccination, this provides circumstantial evidence
that the 4 proteins are truly released. Further work is
required to determine the exact means by which the
immune system is exposed to these proteins. How-
ever, it is hoped that this work provides further
insight into the developmental biology of the parasite
by identifying novel genes, but more importantly
yields potential targets for chemotherapeutic and}or
immunological intervention.
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